z-logo
open-access-imgOpen Access
Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
Author(s) -
Om Kurmi,
Julien Vaucher,
Dan Xiao,
Michael V. Holmes,
Canqing Yu,
Kourtney J. Davis,
Wang Chen,
Haiyan Qin,
Iain Turnbull,
Peng Peng,
Zheng Bian,
Robert Clarke,
Liming Li,
Yiping Chen,
Zhengming Chen
Publication year - 2016
Publication title -
international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s100736
Subject(s) - medicine , copd , medical diagnosis , demography , population , cohort , health care , confidence interval , pediatrics , family medicine , environmental health , pathology , sociology , economics , economic growth
COPD is the fourth leading cause of death worldwide, with particularly high rates in the People's Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses. We assessed the validity of COPD diagnoses collected through electronic health records in the People's Republic of China.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom